Q86VM9 (ZCH18_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 69.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Zinc finger CCCH domain-containing protein 18 Alternative name(s): Nuclear protein NHN1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 953 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Subcellular location | Nucleus By similarity. |
| Sequence similarities | Contains 1 C3H1-type zinc finger. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Coiled coil Zinc-finger |
| Ligand | Metal-binding Zinc |
| PTM | Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Cellular component | nucleus Inferred from direct assay. Source: HPA |
| Molecular function | nucleic acid binding Inferred from electronic annotation. Source: InterPro zinc ion bindingInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q86VM9-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q86VM9-2) The sequence of this isoform differs from the canonical sequence as follows: 228-228: M → MKDVVTPLSTLLPPISNSIPFRGQV 412-469: NRQRERERERERDRERERRQRERERERERERDKERQRRKEEWERERAKRDEKDRQHRD → RE 683-953: TLSGSGSGSG...RKRAKIPGKA → LIKEAGSAMN...PARCLGGRSC |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 953 | 953 | Zinc finger CCCH domain-containing protein 18 | PRO_0000311242 | |||||
Regions | |||||||||
| Zinc finger | 219 – 245 | 27 | C3H1-type | ||||||
| Coiled coil | 105 – 134 | 30 | Potential | ||||||
| Coiled coil | 399 – 464 | 66 | Potential | ||||||
| Coiled coil | 921 – 950 | 30 | Potential | ||||||
| Compositional bias | 201 – 204 | 4 | Poly-Asp | ||||||
| Compositional bias | 259 – 296 | 38 | Pro-rich | ||||||
| Compositional bias | 532 – 746 | 215 | Ser-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 46 | 1 | Phosphoserine Ref.4 Ref.9 Ref.11 Ref.12 Ref.14 | ||||||
| Modified residue | 67 | 1 | Phosphoserine Ref.4 Ref.11 Ref.14 | ||||||
| Modified residue | 74 | 1 | Phosphoserine Ref.4 Ref.11 | ||||||
| Modified residue | 78 | 1 | Phosphoserine Ref.4 Ref.11 | ||||||
| Modified residue | 83 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 95 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 109 | 1 | Phosphothreonine Ref.11 | ||||||
| Modified residue | 110 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 487 | 1 | Phosphoserine Ref.4 Ref.7 | ||||||
| Modified residue | 532 | 1 | Phosphoserine Ref.4 Ref.5 Ref.10 Ref.11 Ref.12 | ||||||
| Modified residue | 534 | 1 | Phosphoserine Ref.4 Ref.5 Ref.6 Ref.8 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 | ||||||
| Modified residue | 599 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 601 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 603 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 604 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 605 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 607 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 609 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 611 | 1 | Phosphothreonine Ref.4 | ||||||
| Modified residue | 613 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 677 | 1 | Phosphothreonine Ref.4 | ||||||
| Modified residue | 842 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 852 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 857 | 1 | Phosphoserine Ref.4 | ||||||
| Modified residue | 868 | 1 | Phosphoserine Ref.4 Ref.6 Ref.10 Ref.13 | ||||||
| Modified residue | 893 | 1 | Phosphoserine Ref.4 | ||||||
Natural variations | |||||||||
| Alternative sequence | 228 | 1 | M → MKDVVTPLSTLLPPISNSIP FRGQV in isoform 2. | VSP_029453 | |||||
| Alternative sequence | 412 – 469 | 58 | NRQRE…RQHRD → RE in isoform 2. | VSP_029454 | |||||
| Alternative sequence | 683 – 953 | 271 | TLSGS…IPGKA → LIKEAGSAMNHQTRTGRALL QPSGPTHPQTEVLGTGSQVG DWAPRSQSGREARTPKPLQP RLTGSASCHPSPRAPARSRA CPAKPRIPAPPAPNQGRPAR CLGGRSC in isoform 2. | VSP_029455 | |||||
| Natural variant | 368 | 1 | A → T. Corresponds to variant rs34808360 [ dbSNP | Ensembl ]. | VAR_037188 | |||||
| Natural variant | 440 | 1 | R → H. Ref.3 Corresponds to variant rs17855686 [ dbSNP | Ensembl ]. | VAR_037189 | |||||
Experimental info | |||||||||
| Sequence conflict | 251 | 1 | Y → H in BAB71237. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| [1] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Brain. |
| [2] | "The sequence and analysis of duplication-rich human chromosome 16." Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J. Pennacchio L.A.Nature 432:988-994(2004) [PubMed: 15616553] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT HIS-440. Tissue: Cervix and Testis. |
| [4] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46; SER-67; SER-74; SER-78; SER-83; SER-487; SER-532; SER-534; SER-599; SER-601; SER-603; SER-604; SER-605; SER-607; SER-609; THR-611; SER-613; THR-677; SER-842; SER-857; SER-868 AND SER-893, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [5] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-532 AND SER-534, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [6] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-534 AND SER-868, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [7] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-487, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [8] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-534, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed: 19367720] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, MASS SPECTROMETRY. Tissue: T-cell. |
| [10] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-532; SER-534 AND SER-868, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46; SER-67; SER-74; SER-78; SER-95; THR-109; SER-110; SER-532 AND SER-534, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46; SER-532 AND SER-534, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [13] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-534 AND SER-868, MASS SPECTROMETRY. |
| [14] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46; SER-67 AND SER-534, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [15] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AK056632 mRNA. Translation: BAB71237.1. AC116552 Genomic DNA. No translation available. BC001584 mRNA. Translation: AAH01584.1. BC050463 mRNA. Translation: AAH50463.1. |
| IPI | IPI00293312. IPI00328929. |
| RefSeq | NP_653205.3. NM_144604.3. |
| UniGene | Hs.93670. |
3D structure databases | |
| ProteinModelPortal | Q86VM9. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q86VM9. 3 interactions. |
PTM databases | |
| PhosphoSite | Q86VM9. |
Polymorphism databases | |
| DMDM | 269849528. |
Proteomic databases | |
| PRIDE | Q86VM9. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000301011; ENSP00000301011; ENSG00000158545. |
| GeneID | 124245. |
| KEGG | hsa:124245. |
| UCSC | uc002fky.1. human. |
Organism-specific databases | |
| CTD | 124245. |
| GeneCards | GC16P088636. |
| H-InvDB | HIX0013334. |
| HGNC | HGNC:25091. ZC3H18. |
| HPA | HPA040847. HPA041327. |
| neXtProt | NX_Q86VM9. |
| PharmGKB | PA162409533. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG10161. |
| GeneTree | ENSGT00580000081375. |
| HOVERGEN | HBG103346. |
| InParanoid | Q86VM9. |
| OrthoDB | EOG46T31J. |
| PhylomeDB | Q86VM9. |
Gene expression databases | |
| ArrayExpress | Q86VM9. |
| Bgee | Q86VM9. |
| CleanEx | HS_ZC3H18. |
| Genevestigator | Q86VM9. |
Family and domain databases | |
| InterPro | IPR000571. Znf_CCCH. [Graphical view] |
| KO | K13092. |
| SMART | SM00356. ZnF_C3H1. 1 hit. [Graphical view] |
| PROSITE | PS50103. ZF_C3H1. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 81250. |
Entry information
| Entry name | ZCH18_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q86VM9 Secondary accession number(s): Q96DG4, Q96MP7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| SIMILARITY comments Index of protein domains and families |

Clusters with